Search results for: Karla Hernandez-Villafuerte
Filter search results
OHE Presentations at HTAi: Tokyo 2016
24 May 2016
…Development in Middle-In come Countries by Karla Hernandez-Villafuerte Options for Formulary Development in Middle-Income Countries by Karla Hernandez-Villafuerte A number of middle-income countries (MICs) are evolving their health systems toward…
Spotlight on OHE: Competition in the NHS, HESG, Publications
17 July 2014
…very practical policy issues. HESG meets twice a year, most recently in June 2014. Two OHE papers were discussed at the most recent HESG meeting. A paper by Karla Hernandez-Villafuerte and…
OHE at EuHEA 2016: Opportunity Costs, Value Based Pricing, Economies of Scope and Quality of Life
17 August 2016
…scope and scale in publicly funded biomedical and health research by Karla Hernandez-Villafuerte Publicly funded biomedical and health research is expected to achieve significant returns for taxpayers and for society…
Spotlight on OHE: NICE, Biosimilars, HTA
17 June 2014
…countries and the importance of HTA. Comparison of Health Care Systems in Latin America: Pharmaceuticals Villafuerte 2014 from Office of Health Economics For additional information, please contact Karla Hernández-Villafuerte. …
OHE Workshop: Surrogate Endpoints as Predictors of Overall Survival in Oncology
14 July 2016
…and triallists of the issues surrounding the validation of surrogates. OHE’s Dr Karla Hernandez-Villafuerte presented the preliminary results of a systematic review that she is undertaking to identify the principal…
Issues Surrounding the Estimation of the Opportunity Cost of Adopting a New Health Care Technology: Areas for Further Research
1 August 2018
This OHE Research paper by Karla Hernandez-Villafuerte, (German Cancer Research Center, DKFZ), Bernarda Zamora (OHE) and Adrian Towse (OHE) sets out a research agenda proposing new approaches in three areas…
OHE at ISPOR Europe: Posters
13 November 2014
…Ispor do nice_decisions_affect_decisions_in_other_countries from Office of Health Economics Karla Hernandez-Villafuerte, Paul Barnsley, Martina Garau and Nancy Devlin Ispor opportunity costs_sks from Office of Health Economics Sarah Karlsberg Schaffer, Jon…